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The tropical freshwater zebrafish has recently emerged as a valuable model 18 
organism for the study of adipose tissue biology and obesity-related disease. The 19 
strengths of the zebrafish model system are its wealth of genetic mutants, transgenic 20 
tools and amenability to high-resolution imaging of cell dynamics within live animals. 21 
However, zebrafish adipose research is at a nascent stage and many gaps exist in our 22 
understanding of zebrafish adipose physiology and metabolism. By contrast, adipose 23 
research within other, closely-related, teleost species has a rich and extensive history, 24 
owing to the economic importance of these fish as a food source. Here we compare and 25 
contrast knowledge on PPARG-mediated adipogenesis derived from both biomedical and 26 
aquaculture literatures. We first concentrate on the biomedical literature to; (i) briefly 27 
review PPARG-mediated adipogenesis in mammals, before (ii) reviewing Pparg-28 
mediated adipogenesis in zebrafish. Finally, we (iii) mine the aquaculture literature to 29 
compare and contrast Pparg-mediated adipogenesis in aquaculturally-relevant teleosts. 30 
Our goal is to highlight evolutionary similarities and differences in adipose biology that will 31 
inform our understanding of the role of adipose tissue in obesity and related disease.   32 




Adipogenesis - the process of progenitor cell differentiation to generate mature, 33 
lipid-laden adipocytes (fat cells), is central to physiological homeostasis. Dysregulation of 34 
adipogenesis, and a reduced capacity to sequester lipid within cytoplasmic lipid droplets 35 
(LDs) of adipocytes, leads to lipodystrophy, ectopic lipid deposition, systemic metabolic 36 
dysfunction and increased risk for developing diabetes and cardiovascular disease (1-3). 37 
Members of the Peroxisome proliferator-activated receptor (PPAR) family of nuclear 38 
receptors have paramount roles in lipid metabolism; and, in particular, PPAR gamma 39 
(PPARG) is critical for adipogenesis. Much is known on PPARG-mediated adipogenesis 40 
in mammalian model systems; however, extensive research has also been conducted on 41 
adipogenesis in fish species relevant to the aquaculture industry. The aim of this mini-42 
review is to integrate findings on Pparg-mediated adipogenesis from the aquaculture 43 
industry into the larger biomedical-centered literature. This review is focused on 44 
adipogenesis in white adipose tissue (WAT); however, adipogenesis in brown adipose 45 
has also recently been reviewed (4).  46 
 47 
PPARG: a master regulator of mammalian adipogenesis  48 
PPARG is both necessary and sufficient for WAT adipogenesis in mammals, and 49 
is considered a ‘master regulator’ of adipogenesis. In mouse, Pparg plays an important 50 
role in placental vascularization, monocyte differentiation and cardiac development (5, 6); 51 
however, Pparg is also required for adipogenesis both in vitro (7) and in vivo (5, 7, 8). 52 
Naturally occurring mutations within the PPARG coding sequence can lead to PPARG 53 
loss-of-function (LOF), severe lipodystrophy, insulin resistance, and diabetes in humans 54 
(2, 3, 9). Further, adipocyte-specific deletion of Pparg in mouse results in the complete 55 
absence of WAT (8). Strikingly, expression of Pparg, together with provision of an 56 
activating ligand, is sufficient to initiate an adipogenic program and maintain an adipocyte 57 
phenotype in previously non-adipogenic cells (10, 11). Therefore, PPARG has a central 58 
role in mammalian adipogenesis, typified by PPARG LOF in humans which is associated 59 
with severe lipodystrophy, and metabolic dysfunction and disease. 60 




In mammals, PPARG exists as two isoforms, G1 (γ1) and G2 (γ2), derived from a 61 
single gene, and transcribed by distinct promoters (12, 13). PPARG2 contains an 62 
additional 30 amino acids at the N-terminal of PPARG1, and is specific to WAT - whereas, 63 
PPARG1 can be expressed at low levels in non-WAT tissues (12, 13). Both γ1 and γ2 64 
isoforms can instruct a similar adipogenic gene expression program; however, PPARG2 65 
exhibits a quantitatively greater adipogenic ability (14). Structurally, PPARG contains six 66 
protein domains (domains A-F) (Fig. 1A): the N-terminal A/B-domain contains the ligand-67 
independent transactivation function 1 (AF-1); the C-domain is a highly conserved DNA-68 
binding domain (DBD), consisting of two type II zinc fingers; the D-domain is a flexible 69 
hinge region; the E-domain contains the AF-2 ligand-binding domain (LBD); and at the C-70 
terminus, a small F-domain has been shown to interact with co-factors (15).   71 
The function of each PPARG domain has been extensively studied. The N-terminal 72 
AF-1 domain regulates the transcriptional activity of PPARG by (i) influencing Pparg 73 
ubiquitination and receptor turnover (16), (ii) controlling localization of Pparg to distinct 74 
cellular compartments (17, 18), (iii) facilitating communication with the LBD and 75 
enhancing ligand-dependent transcription (19), and (iv) recruitment of coactivators (20, 76 
21) and corepressors (22). Importantly, many AF-1 focused regulatory mechanisms rely 77 
on post-transcriptional modifications of PPARG, and can be both ligand-dependent or 78 
ligand-independent (23). Accordingly, inhibiting phosphorylation of serine 112 (S112) of 79 
Pparg2 in mouse results in improved insulin sensitivity when fed a high-fat diet (24). In 80 
addition humans carrying a mutation blocking phosphorylation of an equivalent serine 81 
residue also have improved insulin sensitivity (18, 25). Together, these studies show that 82 
multiple diverse mechanisms converge on the AF-1 domain to regulate the transcriptional 83 
activity, and insulin sensitizing potential, of PPARG. 84 
The transcriptional activity of PPARG is highly dependent on its DBD. Mutations 85 
within the DBD of human PPARG inhibit the transcriptional potential of PPARG, and 86 
patients carrying such mutations exhibit severe insulin resistance and an increased risk 87 
for diabetes (3, 9, 26). The core DBD is highly conserved between different nuclear 88 
receptors; both within the PPAR family, and between distinct nuclear receptor families 89 
(27). Indeed, some nuclear receptors bind identical DNA motifs (28) and, in support, 90 




Pparg retains the ability to conduct an adipogenic program even when fused to alternative 91 
DBDs (29). These data suggest the specificity of PPARG-mediated gene activation is not 92 
entirely contained within the DBD. Pparg generally binds DNA as obligate heterodimers 93 
with members of the Retinoid X Receptor (RXR) family of nuclear receptors (30), although 94 
some evidence suggests Pparg can also function as a homodimer (31). Strikingly, 95 
mutations within RXR DBDs have severe consequences for the transcriptional activity of 96 
Pparg:Rxr heterodimers, suggesting the DNA-binding activity of RXR is also central to 97 
PPARG function (32). PPARG/RXR heterodimers bind to cis-acting peroxisome 98 
proliferator response elements (PPREs) containing direct repeats of 5’-AGGTCA-3’ 99 
separated by n nucleotides (DRn) (Fig. 1B) (33-35). Along with an AAACT flanking 100 
sequence situated immediately 5’ to the core DRn motif, which helps guide selective 101 
PPAR binding (36-38). ChIP-Seq analyses for Pparg binding have identified DR1 as the 102 
canonical motif for PPARG binding (33, 39, 40), and binding is dependent on the 103 
sequence, and affinity, of specific DR1 motifs (40). Wider chromatin organization and 104 
accessibility also appear key for PPARG-mediated adipogenesis, as extensive chromatin 105 
remodeling occurs early in adipogenesis, prior to Pparg binding, and creates ‘hotspots’ 106 
primed for future Pparg binding (41). 107 
 108 
The ligand binding domain of PPARG, known ligands, and modulation 109 
of transcriptional activity 110 
Ligand binding regulates the transcriptional activity of PPARG and, as such, the LBD is 111 
central to the ability of PPARG to direct adipogenesis and regulate insulin sensitivity. 112 
Numerous lipid metabolites have been identified as PPARG ligands; including, 113 
polyunsaturated fatty acids (such as docosahexaenoic acid and linoleic acid), 114 
eicosanoids, and 15-deoxy-Δ12,14-prostanglandin J2 (PGJ(2)) (10, 42-47). Many of 115 
these ligands bind PPARG with low affinity and are unlikely to be present at 116 
concentrations required to activate PPARG in vivo (48). However, derivatives of linoleic 117 
acid have been shown to potently bind Pparg, and may represent an endogenous ligand 118 
for PPARG (49, 50). Intriguingly, a cAMP-induced, transient Pparg ligand is produced by 119 
3T3-L1 adipocytes during the early stages of adipogenesis (51) and drives Pparg-120 




mediated progenitor differentiation. Furthermore, this transient Pparg ligand is suggestive 121 
of a positive feedback loop, which is autonomous to adipocytes and acts in a paracrine 122 
manner. Synthetic ligands also bind and regulate PPARG activity. Most prominently, 123 
thiazolidinediones (TZDs) are potent PPARG agonists that lower hyperglycemia, 124 
decrease plasma triacylglycerides and free fatty acids, and increase insulin sensitivity 125 
(51). As such, TZDs have incredible potential to improve insulin sensitivity and glucose 126 
homeostasis in diabetic patients. However, many TZDs have been withdrawn from clinical 127 
use, or are under extensive review, owing to toxic side-effects (52, 53). In particular, TZDs 128 
induce adipogenesis in patients and can lead to increased weight gain (51, 54, 55). 129 
 130 
Zebrafish as a model to study Pparg-mediated adipogenesis  131 
As a complement to mammalian model systems, the zebrafish has recently 132 
emerged as a tractable model for studying adipogenesis in vivo. Zebrafish possess 133 
adipose tissue that is morphologically similar to mammalian WAT (56-58), and which is 134 
deposited in anatomically homologous regions to mammalian WAT (56, 58, 59). Further, 135 
zebrafish adipose responds to nutritional manipulation, suggesting a conserved role for 136 
WAT as an energy store or supply during periods of caloric excess or restriction (56, 60, 137 
61). Zebrafish possess a single pparg ortholog on chromosome 11 (47), which exhibits 138 
67% overall similarity to human PPARG (47). The LBD and DBD of zebrafish pparg show 139 
especially high conservation to human PPARG (80.5% and 94.3% of amino acids are 140 
identical in LDB and DBD respectively) (Fig. 1C) (47, 62). The N-terminal AF-1 domain 141 
shows much less conservation between zebrafish and human (Fig. 1C) (47, 62); however, 142 
this is unsurprising as the AF-1 domain is well known to exhibit low similarity even 143 
between more closely related species (23). Interestingly, zebrafish pparg contain multiple 144 
regions with amino acid insertions not present in mammalian PPARG, suggesting the 145 
potential for neo-functionalization of fish Pparg (Fig. 1C) (47). Importantly, zebrafish pparg 146 
mRNA is detected in adipocytes (56, 58, 60). Moreover, many compounds known to 147 
stimulate mammalian Pparg also modulate zebrafish pparg mRNA; including, organotin 148 
compounds such as tributyltin (63, 64), halogenated analogs of bisphenol A (65), and 149 
PGJ(2) (66). Construction of a zebrafish transgenic line expressing the human PPARG 150 




LBD fused to a Gal4 DBD, exhibits increased transcriptional activity after treatment with 151 
TZDs including rosiglitazone, pioglitazone or troglitazone (67), thus suggesting that 152 
ligand-dependent co-activators of Pparg are conserved and functional in zebrafish. 153 
Intriguingly, recent work showed that treatment of zebrafish with the TZD rosiglitazone 154 
increased adiposity, suggesting that the role of Pparg in stimulating zebrafish 155 
adipogenesis may also be conserved to mammals (68).  156 
 157 
Adipogenesis and the aquaculture industry  158 
The use of zebrafish as a biomedical model system to study adipogenesis is at a 159 
nascent stage, and many gaps exist in our understanding. However, the aquaculture 160 
industry has conducted extensive investigation into adipogenesis in closely related fish 161 
species, owing to the fact that adipogenesis affects meat quality, animal health and 162 
harvest yields (69). Aquaculture is defined as the farming of aquatic organisms; including 163 
fish, crustaceans, molluscs and plants. The aquaculture industry contributes ~50% of the 164 
world’s aquatic food source (70); thus representing a significant proportion of all food 165 
consumed worldwide (71). For this review we focus on teleost species most closely 166 
related to zebrafish. For a comprehensive review of teleost phylogeny, we refer you to 167 
the following articles (72, 73). The teleost lineage is divided into three branches; 168 
clupeocephalans (including the majority of teleosts); and the relatively minor elopomorpha 169 
(including eels and tarpons), and osteoglossomorpha (fish possessing toothed or bony 170 
tongues) (72, 73). For this review, we only consider clupeocephalans, which belong to 171 
two main lineages; ostariophysi and euteleostei. In 2010, freshwater fish production was 172 
dominated by ostariophysi such as silver carp (Hypophthalmichthys molitrix), grass carp 173 
(Ctenopharyngodon idella), common carp (Cyprinus carpio), and the euteleostei, Nile 174 
tilapia (Oreochromis niloticus). The euteleostei Atlantic salmon (Salmo salar) was the 175 
most farmed saltwater fish (70). Extensive regional differences exist in the species of fish 176 
farmed; for example, Asian countries primarily farm ostariophysi carp species, accounting 177 
for 89% of world aquaculture (70). By contrast, Mediterranean countries farm euteleostei 178 
species including gilthead sea bream (Sparus aurata) (74), European sea bass 179 
(Dicentrarchus labrax), and flathead gray mullet (Mugil cephalus) (70). Northern 180 




European countries, primarily farm euteleostei salmonid species such as Atlantic salmon 181 
and rainbow trout (Oncorhynchus mykiss) (70). A characteristic of teleosts is a teleost-182 
specific 3rd whole genome duplication (WGD) (Ts3R), which is estimated to have occurred 183 
~225-333 million years ago (72, 75). Recent genome sequencing projects have revealed 184 
that, in addition to Ts3R, certain teleost lineages have undergone further extensive 185 
genome duplication; including, salmonids (76, 77) and common carp (78). Genome 186 
duplications are hypothesized to underlie the dramatic radiation of teleosts and often lead 187 
to multiple gene copies, under reduced selective constraint, and thus receptive to neo-, 188 
non- and sub-functionalization of the ancestral gene role (73). 189 
 190 
Extensive syntenic conservation at teleost pparg loci  191 
As PPARG exerts such a central role in mammalian adipogenesis, we first wished 192 
to assess whether duplicated teleost pparg paralogs have been retained. Only a single 193 
pparg ortholog was identified in 9 (of 10) teleost fish species with genome data on 194 
Ensembl (79). These data are striking, as the other members of the PPAR family (ppara 195 
and ppard) have been extensively duplicated, with paralogs retained, in teleosts (Ensembl 196 
Gene Tree: ENSGT00870000136388) (47). Teleost species with a single pparg ortholog 197 
include, ostariophysi such as zebrafish (cyprinidae); and euteleostei such as, Atlantic cod 198 
(gadiformes), pufferfish (tetradontiformes, both fugu and tetraodon), stickleback 199 
(gasterodae), and Nile tilapia (cichlidae) (Ensembl Gene Tree: ENSGT00870000136388) 200 
(47). The single teleost species with a retained pparg paralog is the ostariophysi blind 201 
cavefish (Astyanax mexicanus) of the chariciformes order (Fig. 2). The striking loss of 202 
duplicated pparg genes in the majority of teleosts suggest stringent selective pressures 203 
for retaining Pparg copy number and function. To construct a predicted ancestral pparg 204 
locus, we examined synteny at the Pparg locus in tetrapods (mouse and human), a basal 205 
sarcopterygian (coelacanth), an actinopterygian holosteian basal to teleosts (spotted gar) 206 
and a chondrichthyan, cartilaginous fish (elephant shark) (Fig. 2). Following the Ts3R, 207 
two pparg loci can be identified which each share extensive synteny to the predicted 208 
ancestral locus (Fig. 2). Remarkably, in both ostariophysi and euteleostei, pparg 209 
appeared to be retained at a specific single locus (locus 1) (Fig. 2), with the exception 210 




being Atlantic salmon which retained pparg at locus 2 (Fig. 2). Strikingly, in all euteleostei 211 
species examined the region downstream of pparg contained multiple new genes not 212 
found in other species (iffo2b, akr7a3, mrto4, megf6b), suggesting an euteleostei-specific 213 
recombination event that completely changed the sequence downstream of pparg (Fig. 214 
2).  215 
 216 
Sequence homology of teleost pparg genes  217 
Extensive synteny at teleost and mammalian PPARG suggest the locus is under 218 
considerable selective constraint; therefore, we next assessed whether the PPARG 219 
amino acid sequence was equally conserved. We aligned PPARG sequences from 220 
representative tetrapods, a basal sarcopterygian, a holosteian, an ostariophysan, and 221 
euteleostians (Fig. 1C). As expected, not all elements of the mammalian PPARG 222 
sequence were conserved from mammals to fish (Fig. 1C). Strikingly, the DBD, hinge 223 
region and LDB exhibited high levels of conservation from mammals to fish (Fig. 1C). 224 
However, we found a large insertion into the hinge region specific to the euteleosts, fugu 225 
and Nile tilapia (Fig. 1C). We further found euteleost-specific and zebrafish-specific 226 
insertions into the AF-1 domain (Fig. 1C). Aside from these three regions inserted into 227 
teleost Pparg, conservation was extensive (Fig. 1C). Previous studies have identified that 228 
the LDB of fish Pparg (red sea bream and Nile tilapia) often contains additional amino 229 
acids compared to human PPARG (80, 81). However, the DBD of PPARG is well 230 
conserved between fish and mammals (81). These distinct patterns of conservation have 231 
been suggested to reflect the fact that PPARG target genes are well conserved, while 232 
there may be greater diversity in ligands which activate PPARG (81), and may explain 233 
why some human PPARG agonists are unable to stimulate pparg expression across 234 
teleost species (81, 82). 235 
 236 
Conservation of Pparg amino acids affected by disease-associated 237 
genetic variation in humans 238 




The considerable sequence conservation between mammalian and teleost 239 
PPARG suggest that residues affected by naturally occurring, disease-associated, 240 
mutations in human PPARG may also be conserved in teleosts. To address this we (i) 241 
collected all known human PPARG single nucleotide polymorphisms (SNPs) from dbSNP 242 
(347 SNPs), (ii) filtered these SNPs to identify 73 SNPs predicted to have a highly 243 
deleterious effect on PPARG function, (iii) identified amino acids altered by the 244 
deleterious SNPs which were conserved to teleosts (39 SNPs/amino acids), (iv) filtered 245 
the conserved deleterious SNPs to ones that had been experimentally verified to have an 246 
effect on adipogenesis and PPARG function in humans (4 SNPs) (9). The resulting 247 
collection of SNPs (Fig. 1C) represent ideal initial targets for modelling Pparg function 248 
during teleost adipogenesis, and highlight the highly conserved nature of PPARG from 249 
mammals to fish. 250 
 251 
Expression dynamics of pparg in farmed fish species  252 
Although little is known regarding the expression of pparg in zebrafish, extensive 253 
experiments have been undertaken in farmed fish species to determine the dynamics of 254 
pparg during adipogenesis. In grass carp (ostariophysi), gilthead sea bream, large yellow 255 
croaker, and Atlantic salmon (all euteleostei), Pparg/pparg appeared coincident with early 256 
stages of adipocyte differentiation and increased gradually throughout adipogenesis (69, 257 
83-87). These dynamics mirror those observed in mammalian 3T3-L1 cells, where Pparg 258 
mRNA is present at low levels in adipocyte progenitors, and increases upon stimulation 259 
of adipogenesis (10, 88). Similar to 3T3-L1 cells, cebpb mRNA was also induced prior to 260 
pparg during differentiation of adipocyte progenitors in the euteleostei, cobia 261 
(Rachycentron canadum) and in Atlantic Salmon (89). By contrast, in red sea bream 262 
(Pagrus major) (another euteleostei), pparg mRNA appeared to remain stable during a 263 
ten day preadipocyte culture; however, isolated cells were maintained for 4 days prior to 264 
induction of adipogenesis, therefore it remains possible that fluctuations in pparg mRNA 265 
expression occurred prior to analysis (80). However, by this method accumulation of LDs 266 
appeared late and was not robust (80). Furthermore, in  gilthead sea bream (euteleostei) 267 
pparg mRNA decreased in preadipocytes upon the addition of an adipogenic cocktail (83). 268 




The experimental reasons for differences in teleost pparg expression dynamics is unclear; 269 
however, in most fish species the induction and maintenance of pparg mRNA during 270 
adipogenesis appears largely conserved to mammals. Furthermore, multiple pparg 271 
isoforms have been found in Nile tilapia and Atlantic salmon (both long and short 272 
isoforms) (81, 85, 90, 91), suggesting that teleost pparg is alternatively spliced similar to 273 
mammalian PPARG. 274 
 275 
The functional role of Pparg-mediated adipogenesis in farmed fish 276 
species  277 
In addition to expression dynamics, extensive experiments on Pparg-mediated 278 
adipogenesis have been conducted in aquaculturally-relevant fish species. Much of the 279 
evidence for Pparg-mediated adipogenesis in fish species, derive from primary adipocyte 280 
progenitor, or ‘preadipocyte’, cell culture systems. Primary preadipocyte cultures have 281 
been established in multiple species, including; Atlantic salmon (84), red sea bream (92), 282 
rainbow trout (93), grass carp (94), large yellow croaker (69), gilthead sea bream (74) 283 
and cobia (89). In all of these systems, primary stromal-vascular cells (SVCs) were 284 
isolated from VAT (visceral adipose tissue) (the VAT source most likely equates to the 285 
pancreatic VAT (PVAT) and abdominal VAT (AVAT) deposits described in zebrafish (59)). 286 
The preadipocyte culture methods closely follow established methods for the growth and 287 
differentiation of mammalian 3T3-L1 cells (95), and enable the incubation of 288 
preadipocytes, and differentiated adipocytes, with a range of pharmacological and 289 
biological agents to study potential roles during Pparg-mediated adipogenesis.  290 
To our knowledge, no functional genetic data on the role of Pparg in farmed fish 291 
species is currently published. However, extensive data exists on pharmacological 292 
manipulation of Pparg and adipogenesis. Troglitazone, an insulin sensitizing TZD, 293 
potently stimulates preadipocyte differentiation in porcine and human preadipocytes (96, 294 
97); and co-incubation with insulin induced preadipocyte differentiation in rainbow trout 295 
(98). A second TZD tested in teleosts, ciglitazone, induced pparg expression in 296 
preadipocytes of red sea bream (80), suggesting that TZDs induce both pparg and 297 




adipogenesis in teleosts. The role of several pro- and anti-adipogenic factors have also 298 
been studied in fish. Insulin has potent stimulatory effects on Pparg mRNA levels, and 299 
the proliferation and differentiation of mammalian preadipocytes, acting through IRS1 and 300 
the MAPK pathway (99, 100). In large yellow croaker (Percomorpha), insulin increased 301 
pparg mRNA, along with stimulating preadipocyte proliferation and differentiation (69). In 302 
accord with inhibiting lipolysis in differentiated adipocytes, which was also observed in 303 
rainbow trout (69, 101). Similarly, insulin also stimulated the differentiation of adipocyte 304 
progenitors and lipid accumulation in red sea bream (92). These findings suggest that 305 
insulin has a conserved role in stimulating pparg expression and promoting adipogenesis. 306 
Insulin-mediated induction of pparg and adipogenesis is also potentially conserved to 307 
other fish species, as the insulin-IRS1-MAPK signaling axis is also functional in rainbow 308 
trout adipocytes (102). However, unlike in rainbow trout, insulin had no effect on adipocyte 309 
lipolysis in gilthead sea bream (103). Tumour necrosis factor alpha (Tnfa) is secreted from 310 
mammalian adipocytes and inhibits adipogenesis (104). Treating large yellow croaker 311 
preadipocytes with human TNFA reduced pparg mRNA levels, suppressed proliferation 312 
and differentiation, and stimulated lipolysis in differentiated adipocytes (69). An anti-313 
adipogenic role for TNFA was also found in rainbow trout adipocytes at both RNA and 314 
protein levels (93, 105). Polyunsaturated fatty acids (PUFAs) inhibit the proliferation and 315 
differentiation of mammalian preadipocytes (106, 107). DHA, an omega-3 fatty acid, was 316 
used in the treatment of large yellow croaker preadipocytes and led to decreased pparg 317 
mRNA levels and reductions in cell proliferation (69). It has further been shown that DHA 318 
stimulates lipolysis in 3T3-L1 preadipocytes (108); however, DHA did not exert a positive 319 
effect on lipolysis within large yellow croaker adipocytes, and was actually observed to 320 
have an anti-lipolytic effect (69). Interestingly, DHA reduced lipid accumulation in Atlantic 321 
salmon adipocytes, although a mechanisms by which this occurred was not identified 322 
(85). Conversely, an analog of the saturated fatty acid palmitate, 2-bromopalmitate, 323 
increased pparg mRNA (red sea bream) (80). pparg cooperates with rxra to transcribe 324 
fabp4 suggesting that fish Pparg also functions as an obligate heterodimer with Rxr 325 
proteins to guide adipogenic gene expression (Nile tilapia) (81). In Atlantic salmon, pparg 326 
mRNA was induced after addition of Liver x receptor (lxr) agonists (109), suggesting 327 
Pparg:Lxr coordinate gene expression in teleosts as they do in mammals (110).  328 





Conclusions and future directions 330 
PPARG is a master regulator of adipogenesis in mammals, and mutations 331 
deleterious to PPARG function lead to increased susceptibility to diabetes and 332 
cardiovascular disease. In this review, we assessed the literature on Pparg-mediated 333 
adipogenesis in teleost fish species, including the biomedical model system, zebrafish, 334 
and multiple aquaculturally-relevant farmed fish species. We found a high degree of 335 
synteny and conservation at/in pparg in teleost fish, along with evidence of conserved 336 
expression, regulation and function derived from primary preadipocyte culture studies. 337 
Altogether, information on the role of Pparg gleaned from aquaculturally-relevant species 338 
is likely to be highly informative for future zebrafish and mammalian biomedical studies 339 
on adipogenesis.    340 
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Figure legends 605 
Figure 1. Overview of PPARG structure, DNA binding specificity and identification 606 
of human PPARG genetic variation conserved to fish. A. Schematic illustrating the 607 
domain organization of human PPARG. B. PPARG:RXRA binding motifs for human 608 
(upper motif) and mouse (lower motif). Motifs are derived from the JASPAR database 609 
(http://jaspar.genereg.net/). C.  PPARG domain structure with dbSNPS predicted to be 610 
deleterious using SIFT and Polyphen, and conserved to zebrafish, Nile tilapia and fugu. 611 
Red SNPs indicate functional verification (9). Yellow-brown histogram indicates the 612 
degree of conservation in PPARG between human, mouse, coelacanth, spotted gar, 613 
zebrafish, fugu and Nile tilapia.  Height and colour indicate the degree of conservation. 614 
 615 
Figure 2. Extensive shared synteny between mammals and fish at the PPARG 616 
locus. The predicted ancestral locus was inferred from comparing the loci documented 617 
in the figure, together with the chondrichthyan elephant shark (Callorhinchus milii) locus 618 
(not shown). The C. milii locus contained Cenp and Rab43 genes (indicated with an 619 
asterisk). Ts3R indicates the teleost-specific genome duplication. Note, the inversion of 620 
TIMP4 and SYN2 upstream of PPARG in the mammalian lineage. Duplicated raf1 621 
paralogs (raf1a and raf1b) are only retained in zebrafish and cavefish. 622 


